The Global Coalition on Aging (GCOA) together with the Infectious Diseases Society of America (IDSA) have recently issued a report that evaluates the eleven…
The EU’s Research and Innovation funding programme, Horizon Europe, has launched its research calls for 2021-2022 with an investment of €14.7 billion from the…
AMR is a complex, multi-faceted problem that affects all of society and is driven by many interconnected factors. Antimicrobial-resistant bacteria are found in people,…
The US Senate has reintroduced the Pioneering Antimicrobial Subscriptions to End Up surging Resistance (PASTEUR) Act to spur innovative drug development targeting the most…
BARDA have announced the creation of a new venture to develop and commercialize technologies and medical products to advance health security and prepare for…
The 5-year programme will start in October 2021. Scientists from the Universities of Oxford, Ulster and UCL have joint forces in a multi-disciplinary team…
The Nanotherapeutics hub and iiCON step up the UK’s infectious disease R&D pipeline. iiCON, led by the Liverpool School of Tropical Medicine (LSTM) and…
CARB-X is awarding BioVersys, a pharmaceutical company headquartered in Basel, Switzerland, up to US$4.35 million in non-dilutive funding, to develop a new class of…